BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3872893)

  • 1. Human leukocyte antigens in cutaneous T cell lymphoma.
    Rosen ST; Radvany R; Roenigk H; Terasaki PI; Bunn PA
    J Am Acad Dermatol; 1985 Mar; 12(3):531-4. PubMed ID: 3872893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis of cutaneous lymphomas.
    Stadler R; Stranzenbach R
    Exp Dermatol; 2018 Oct; 27(10):1078-1083. PubMed ID: 29862563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma.
    Jackow CM; McHam JB; Friss A; Alvear J; Reveille JR; Duvic M
    J Invest Dermatol; 1996 Sep; 107(3):373-6. PubMed ID: 8751973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.
    Jiang TT; Cao S; Kruglov O; Virmani A; Geskin LJ; Falo LD; Akilov OE
    J Invest Dermatol; 2024 May; 144(5):1088-1098. PubMed ID: 38036289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of cutaneous T-cell lymphomas.
    Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
    Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
    Horna P; Moscinski LC; Sokol L; Shao H
    Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).
    Wong HK; Mishra A; Hake T; Porcu P
    Br J Haematol; 2011 Oct; 155(2):150-66. PubMed ID: 21883142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides).
    Gupta S; Safai B; Edelson R; Parrott D; Good R
    Cell Immunol; 1980 Mar; 50(1):195-201. PubMed ID: 6967357
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates.
    Haynes BF; Hensley LL; Jegasothy BV
    Blood; 1982 Aug; 60(2):463-73. PubMed ID: 7046848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HLA-DR5 with mycosis fungoides.
    Safai B; Myskowski PL; Dupont B; Pollack MS
    J Invest Dermatol; 1983 May; 80(5):395-7. PubMed ID: 6601679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.
    Hahtola S; Tuomela S; Elo L; Häkkinen T; Karenko L; Nedoszytko B; Heikkilä H; Saarialho-Kere U; Roszkiewicz J; Aittokallio T; Lahesmaa R; Ranki A
    Clin Cancer Res; 2006 Aug; 12(16):4812-21. PubMed ID: 16914566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous T-cell lymphomas. A review of the recent literature.
    Zackheim HS
    Arch Dermatol; 1981 May; 117(5):295-304. PubMed ID: 6971626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome.
    Kawana Y; Suga H; Kamijo H; Miyagaki T; Sugaya M; Sato S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.